Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Irritable Bowel Syndrome

Free Subscription 15.08.2022 4 Aliment Pharmacol Ther 1 Aust N Z J Obstet Gynaecol 1 BMJ Open Gastroenterol 1 Clin Gastroenterol Hepatol 1 Clin Pharmacol Drug Dev 1 Crit Rev Microbiol 1 Curr Gastroenterol Rep 1 Curr Mol Med 2 Front Med (Lausanne) 1 Front Nutr 1 Gastroenterology 1 Gut Microbes 2 Int J Mol Sci 1 J Clin Med 1 J Gastroenterol Hepatol 1 Medicine (Baltimore) 1 Nat Rev Gastroenterol Hepatol 1 Neurogastroenterol Motil 1 Turk J Gastroenterol 1 United European Gastroenterol J

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. INGROSSO MR, Ianiro G, Nee J, Lembo AJ, et al
   Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome.
   Aliment Pharmacol Ther. 2022 Aug 9. doi: 10.1111/apt.17179.
   PubMed         Abstract available
   
   
2. CASTRO TEJERA V, Ohman L, Aabakken L, Fellstrom B, et al
   Randomised clinical trial and meta-analysis: mesalazine treatment in irritable bowel syndrome-Effects on gastrointestinal symptoms and rectal biomarkers of immune activity.
   Aliment Pharmacol Ther. 2022 Aug 8. doi: 10.1111/apt.17182.
   PubMed         Abstract available
   
   
3. GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
   Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply.
   Aliment Pharmacol Ther. 2022;56:894-895.
   PubMed        
   
   
4. SHAH ED, Wechsler EV
   Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome.
   Aliment Pharmacol Ther. 2022;56:892-893.
   PubMed        
   
   

   
   Aust N Z J Obstet Gynaecol

5. RYAN A, Healey M, Cheng C, Dior U, et al
   Central sensitisation in pelvic pain: A cohort study.
   Aust N Z J Obstet Gynaecol. 2022 Aug 11. doi: 10.1111/ajo.13596.
   PubMed         Abstract available
   
   

   
   BMJ Open Gastroenterol

6. KOVACS DB, Szekely A, Hubai AG, Palsson O, et al
   Prevalence, epidemiology and associated healthcare burden of Rome IV irritable bowel syndrome and functional dyspepsia in the adult population of Gibraltar.
   BMJ Open Gastroenterol. 2022;9.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

7. CHAN WW, Grover M
   The COVID-19 Pandemic and Postinfection Irritable Bowel Syndrome: What Lies Ahead for Gastroenterologists.
   Clin Gastroenterol Hepatol. 2022 Aug 6. pii: S1542-3565(22)00601.
   PubMed        
   
   

   
   Clin Pharmacol Drug Dev

8. BOINPALLY R, McGeeney D, Kaczynski E, Weissman D, et al
   An Open-Label Study to Evaluate the Effect of Eluxadoline on the Single-Dose Pharmacokinetics of Midazolam in Healthy Participants.
   Clin Pharmacol Drug Dev. 2022 Aug 8. doi: 10.1002/cpdd.1150.
   PubMed         Abstract available
   
   

   
   Crit Rev Microbiol

9. EFFENDI SSW, Ng IS
   Prospective and challenges of live bacterial therapeutics from a superhero Escherichia coli Nissle 1917.
   Crit Rev Microbiol. 2022 Aug 10:1-17. doi: 10.1080/1040841X.2022.2109405.
   PubMed         Abstract available
   
   

   
   Curr Gastroenterol Rep

10. MA W, Drew DA, Staller K
    The Gut Microbiome and Colonic Motility Disorders: A Practical Framework for the Gastroenterologist.
    Curr Gastroenterol Rep. 2022 Aug 9. pii: 10.1007/s11894-022-00847.
    PubMed         Abstract available
    
    

    
    Curr Mol Med

11. XU R, Liu X, Tian M, Chen D, et al
    Atractylodes-I overcomes the oxidative stress-induced colonic mucosal epithelial cells dysfunction to prevent irritable bowel syndrome via modulating the miR-34a-5p-LDHA signaling pathway.
    Curr Mol Med. 2022 Aug 11. pii: CMM-EPUB-125439.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

12. NABI MY, Nauhria S, Reel M, Londono S, et al
    Endometriosis and irritable bowel syndrome: A systematic review and meta-analyses.
    Front Med (Lausanne). 2022;9:914356.
    PubMed         Abstract available
    
    
13. ZHENG Z, Tang J, Hu Y, Zhang W, et al
    Role of gut microbiota-derived signals in the regulation of gastrointestinal motility.
    Front Med (Lausanne). 2022;9:961703.
    PubMed         Abstract available
    
    

    
    Front Nutr

14. BILAL M, Ashraf S, Zhao X
    Dietary Component-Induced Inflammation and Its Amelioration by Prebiotics, Probiotics, and Synbiotics.
    Front Nutr. 2022;9:931458.
    PubMed         Abstract available
    
    

    
    Gastroenterology

15. GRABAUSKAS G, Gao J, Wu X, Zhou SY, et al
    Gut Microbiota Alter Visceral Pain Sensation and Inflammation via Modulation of Synthesis of Resolvin D1 in Colonic Tuft Cells.
    Gastroenterology. 2022 Aug 4. pii: S0016-5085(22)00829.
    PubMed         Abstract available
    
    

    
    Gut Microbes

16. NABAVI-RAD A, Sadeghi A, Asadzadeh Aghdaei H, Yadegar A, et al
    The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management.
    Gut Microbes. 2022;14:2108655.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

17. KRISHNACHAITANYA SS, Liu M, Fujise K, Li Q, et al
    MicroRNAs in Inflammatory Bowel Disease and Its Complications.
    Int J Mol Sci. 2022;23.
    PubMed         Abstract available
    
    
18. MEADE E, Garvey M
    The Role of Neuro-Immune Interaction in Chronic Pain Conditions; Functional Somatic Syndrome, Neurogenic Inflammation, and Peripheral Neuropathy.
    Int J Mol Sci. 2022;23.
    PubMed         Abstract available
    
    

    
    J Clin Med

19. MATTILA J, Stenholm T, Loyttyniemi E, Koffert J, et al
    Predictive Markers of Crohn's Disease in Small Bowel Capsule Endoscopy: A Retrospective Study of Small Bowel Capsule Endoscopy.
    J Clin Med. 2022;11.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

20. LI X, Ren K, Hong X, Guo S, et al
    Ameliorating Effects of Electroacupuncture on the Low-grade Intestinal Inflammation in Rat Model of Diarrhea-predominant Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2022 Aug 12. doi: 10.1111/jgh.15981.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

21. KIM JH, Yi DY, Lee YM, Choi YJ, et al
    Association between body mass index and fecal calprotectin levels in children and adolescents with irritable bowel syndrome.
    Medicine (Baltimore). 2022;101:e29968.
    PubMed         Abstract available
    
    

    
    Nat Rev Gastroenterol Hepatol

22. CAMILLERI M, Zhernakova A, Bozzarelli I, D'Amato M, et al
    Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies.
    Nat Rev Gastroenterol Hepatol. 2022 Aug 10. pii: 10.1038/s41575-022-00662.
    PubMed         Abstract available
    
    

    
    Neurogastroenterol Motil

23. ZHOU Q, Verne GN
    Epigenetic modulation of visceral nociception.
    Neurogastroenterol Motil. 2022 Aug 10:e14443. doi: 10.1111/nmo.14443.
    PubMed         Abstract available
    
    

    
    Turk J Gastroenterol

24. DEMIROREN K, Guney B, Bostanci M, Ekici D, et al
    A Comparison Between Rome III and Rome IV Criteria in Children with Chronic Abdominal Pain: A Prospective Observational Cohort Study.
    Turk J Gastroenterol. 2022 Aug 10. doi: 10.5152/tjg.2022.21893.
    PubMed         Abstract available
    
    

    
    United European Gastroenterol J

25. BISCHOFF SC, Barazzoni R, Busetto L, Campmans-Kuijpers M, et al
    European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.
    United European Gastroenterol J. 2022 Aug 12. doi: 10.1002/ueg2.12280.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: